Kazia Therapeutics (KZIA) Receivables - Net (2017 - 2025)

Kazia Therapeutics' Receivables - Net history spans 6 years, with the latest figure at $62762.5 for Q2 2025.

  • For Q2 2025, Receivables - Net fell 97.56% year-over-year to $62762.5; the TTM value through Jun 2025 reached $62762.5, down 97.56%, while the annual FY2025 figure was $62762.5, 97.56% down from the prior year.
  • Receivables - Net reached $62762.5 in Q2 2025 per KZIA's latest filing, down from $2.6 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $2.6 million in Q2 2023 to a low of $62762.5 in Q2 2025.
  • Average Receivables - Net over 4 years is $1.3 million, with a median of $1.3 million recorded in 2022.
  • Peak YoY movement for Receivables - Net: skyrocketed 3898.04% in 2023, then plummeted 97.56% in 2025.
  • A 4-year view of Receivables - Net shows it stood at $65180.4 in 2022, then surged by 3898.04% to $2.6 million in 2023, then dropped by 1.45% to $2.6 million in 2024, then tumbled by 97.56% to $62762.5 in 2025.
  • Per Business Quant, the three most recent readings for KZIA's Receivables - Net are $62762.5 (Q2 2025), $2.6 million (Q2 2024), and $2.6 million (Q2 2023).